We are live on ! Find out more
CRDF icon

Cardiff Oncology
CRDF

47 hedge funds and large institutions have $3.84M invested in Cardiff Oncology in 2017 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more call options, than puts

Call options by funds: $2K | Put options by funds: $1K

11% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 9

0.05% more ownership

Funds ownership: 0.15% → 0.2% (+0.05%)

0% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 11

2% less funds holding

Funds holding: 48 → 47 (-1)

10% less capital invested

Capital invested by funds: $4.25M → $3.84M (-$416K)

Holders
47
Holders Change
-1
Holders Change %
-2.08%
% of All Funds
1.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
11
Reduced
11
Closed
9
Calls
$2K
Puts
$1K
Net Calls
+$1K
Net Calls Change
-$5K

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$1.46M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$320K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$304K
4
EP
Elkhorn Partners
Nebraska
+$93.6K
5
VF
Virtu Financial
New York
+$68.5K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$228K
2
ECM
Element Capital Management
New York
-$166K
3
LP
LMR Partners
United Kingdom
-$151K
4
PP
Paloma Partners
Connecticut
-$104K
5
Morgan Stanley
Morgan Stanley
New York
-$55.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
CA
26
Corrado Advisors
New Jersey
$15K +$17.3K +278 New
PCMI
27
Princeton Capital Management Inc
New Jersey
$12K -$15.6K -250 -51%
Goldman Sachs
28
Goldman Sachs
New York
$11K -$228K -3,657 -95%
State Street
29
State Street
Massachusetts
$10K -$9.92K -159 -46%
Morgan Stanley
30
Morgan Stanley
New York
$8K -$55.1K -884 -86%
Citadel Advisors
31
Citadel Advisors
Florida
$8K +$9.23K +148 New
PMFA
32
Plante Moran Financial Advisors
Michigan
$8K +$9.23K +148 New
Bank of America
33
Bank of America
North Carolina
$5K – – –
Simplex Trading
34
Simplex Trading
Illinois
$3K +$2.99K +48 +282%
BWA
35
BDO Wealth Advisors
Florida
$2K – – –
IA
36
IFP Advisors
Florida
$2K – – –
Northwestern Mutual Wealth Management
37
Northwestern Mutual Wealth Management
Wisconsin
$2K – – –
MAM
38
Meeder Asset Management
Ohio
$2K +$873 +14 +64%
CFA
39
Carroll Financial Associates
North Carolina
$1K – – –
Carson Wealth (CWM LLC)
40
Carson Wealth (CWM LLC)
Nebraska
$1K – – –
IP
41
Intellectus Partners
California
$1K – – –
TWA
42
TCI Wealth Advisors
Arizona
$1K +$374 +6 +150%
JP Morgan Chase
43
JP Morgan Chase
New York
$1K +$686 +11 New
Citigroup
44
Citigroup
New York
$1K +$1.75K +28 New
BNP Paribas Financial Markets
45
BNP Paribas Financial Markets
France
$15 – – –
ECM
46
Element Capital Management
New York
– -$166K -1,828 Closed
LP
47
LMR Partners
United Kingdom
– -$151K -1,666 Closed
PP
48
Paloma Partners
Connecticut
– -$104K -1,146 Closed
CS
49
Credit Suisse
Switzerland
– -$14K -157 Closed
Jane Street
50
Jane Street
New York
– -$14K -150 Closed
1
2
3

CRDF Hedge Fund Activity: Q3 2017 in Review

47 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q3 2017, worth a combined $3.84M — down 9.8% from $4.25M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new CRDF positions and 9 closed out — a net gain of 1 holder — while 11 added to existing stakes and 11 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $1.46M. The largest seller was Goldman Sachs, cutting an estimated $228K.

  • 47 institutional investors held Cardiff Oncology (CRDF) as of Q3 2017, down from 48 in Q2 2017.
  • Funds reported $3.84M of Cardiff Oncology stock for Q3 2017, down 9.8% quarter-over-quarter.
  • 10 funds opened new Cardiff Oncology positions in Q3 2017 and 9 closed out, a net change of +1 holder.
  • The largest Cardiff Oncology buyer in Q3 2017 was Sabby Management, an estimated $1.46M added.
  • The largest Cardiff Oncology seller in Q3 2017 was Goldman Sachs, an estimated $228K sold.

Based on aggregated 13F filings for Q3 2017.